Lab In The News
New Insights into the Epigenetic Control of Hematopoiesis
PHILADELPHIA — (June 28, 2018) — Scientists at The Wistar Institute have characterized a novel function for the INTS13 protein that is part of a large protein complex regulating gene transcription, called Integrator.
The Gardini Laboratory
In higher eukaryotes, the process of cell fate determination is at the very core of biological complexity. Genetically identical precursor cells (i.e. stem cells) can execute different transcriptional programs resulting in a wide range of differentiated cell types that are morphologically and functionally distinct. The Gardini lab works to characterize the transcriptional mechanisms that control fate choice and differentiation of human hematopoietic stem cells (figure 1).
In particular, we investigate how genomic regulatory sequences, termed enhancers, work to determine cell identity and specify blood lineages, such as monocytes/macrophages and granulocytes, from hematopoietic stem cells.
Furthermore, we strive to understand how large nuclear multi-protein complexes, such as Integrator and SWI/SNF, fine-tune transcription by coordinating activation of enhancers and their target promoters.
Sandra Deliard, Ph.D.
Avery Zucco, Ph.D.
Yingjie Zhang, Ph.D.
Connor Hill (UPenn-CAMB)
Sarah Offley (UPenn-CAMB)
Sarah Welsh (UPenn-BMB)
Marco Trizzino, Ph.D. (2016-2019) Assistant Professor, Thomas Jefferson University
Elisa Barbieri, Ph.D. (2015-2019) Marie Sklodowska-Curie Fellow, University of Edinburgh
Motivated candidates are encouraged to inquire about the positions below. Contact firstname.lastname@example.org.
Enhancer Regulation in Hematopoiesis and Leukemia
Enhancers are distal regulatory elements scattered throughout the entire genome. They play a fundamental role in orchestrating gene regulation during critical developmental processes such as cell differentiation. Furthermore, enhancers are active spots for transcription of long noncoding RNAs termed eRNAs (Gardini and Shiekhattar, 2015). These short-lived, non-polyadenylated transcripts are required to establish a link between the promoter and the distant regulatory enhancer (chromosomal looping) and contribute to the expression of the target protein-coding gene. The underlying mechanisms are poorly understood and the potential contribution of enhancers and eRNAs to cancer just started to emerge. The lab is keen to understand how a network of enhancers drive the physiological process of hematopoiesis, and how this network is disrupted during leukemogenesis. We recently uncovered a novel enhancer regulatory axis in monocytic and macrophagic differentiation (Barbieri et al., 2018).
Dissecting the Function of the Integrator Protein Complex
Integrator is a large, evolutionarily conserved, multiprotein complex that regulates several transcriptional processes. For instance, Integrator controls pause-release of RNA Polymerase II at several promoters (Gardini et. al., 2014). In addition, Integrator regulates enhancer function through the processing of noncoding eRNAs (Lai, Gardini et al., 2015). We employ a variety of genome-wide techniques, including ChIP-seq, RNA-seq, ATAC-seq and Global Run-On Sequencing (GRO-seq), along with large-scale affinity purification, to study the function of the Integrator complex in cell differentiation.
Role of ARID1A in Transcriptional Regulation
Chromatin remodelers regulate DNA accessibility by positioning nucleosomes at active promoters and enhancers. We investigate the function of SWI/SNF, the most mutated chromatin remodeler across all human cancers. Subunits of SWI/SNF, such as ARID1A, are found mutated in sporadic ovarian tumors and their specific contribution to SWI/SNF activity is poorly understood. We recently elucidated a novel function of ARID1A in pausing of RNA Polymerase II (Trizzino et al., 2018).
Barbieri, E., Trizzino, M., Gardini, A., et al. "Targeted enhancer activation by a subunit of the Integrator complex." Mol Cell. 2018.
Trizzino, M., Barbieri, E., Gardini, A., et al. "The tumor suppressor ARID1A controls global transcription via pausing of RNA Polymerase II." Cell Reports. 2018.
Lai, F., Gardini, A., Shiekhattar, R., et al. "Integrator mediates the biogenesis of enhancer RNAs." Nature. 2015 Sep 17;525(7569):399-403. doi: 10.1038/nature14906. Epub 2015 Aug 26.
Gardini, A., Shiekhattar, R. "The many faces of long noncoding RNAs." FEBS J. 2015 May;282(9):1647-57. doi: 10.1111/febs.13101. Epub 2014 Nov 7.
Gardini, A., Baillat, D., Shiekhattar, R., et al. "Integrator regulates transcriptional initiation and pause release following activation." Mol Cell. 2014 Oct 2;56(1):128-139. doi: 10.1016/j.molcel.2014.08.004. Epub 2014 Sep 4.
Dmitry I. Gabrilovich, M.D., Ph.D.
Christopher M. Davis Professor
Professor & Leader, Immunology, Microenvironment & Metastasis Program